| 113 |
[2015 Oct;39(5)] Increased Epicardial Adipose Tissue Thickness in Type 2 Diabetes Mellitus and Obesity
|
|
2015.12.08 |
7082 |
| 112 |
[2015 Oct;39(5)] The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand
|
|
2015.12.08 |
7445 |
| 111 |
[2015 Oct;39(5)] Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea
|
|
2015.12.08 |
6750 |
| 110 |
[2015 Oct;39(5)] Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three Studies
|
|
2015.12.08 |
7045 |
| 109 |
[2015 Oct;39(5)] Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
|
|
2015.12.08 |
7438 |
| 108 |
[2015 Oct;39(5)] Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
|
|
2015.12.08 |
7016 |
| 107 |
KOREAN DIABETES FACT SHEET 2015
|
 |
2015.11.06 |
7410 |
| 106 |
[2015 Aug;39(4)] Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
|
|
2015.09.08 |
6035 |
| 105 |
[2015 Aug;39(4)] Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
|
|
2015.09.08 |
5710 |
| 104 |
[2015 Aug;39(4)] Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus
|
|
2015.09.08 |
5971 |
| 103 |
[2015 Aug;39(4)] Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
|
|
2015.09.08 |
5735 |
| 102 |
[2015 Aug;39(4)] Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes
|
|
2015.09.08 |
5993 |
| 101 |
[2015 Aug;39(4)] Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
|
|
2015.09.08 |
5192 |
| 100 |
[2015 Aug;39(4)] Probiotics as Complementary Treatment for Metabolic Disorders
|
|
2015.09.08 |
5782 |
| 99 |
[2015 Aug;39(4)] Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
|
|
2015.09.08 |
5572 |
| 98 |
[2015 Aug;39(4)] Glycemic Variability: How Do We Measure It and Why Is It Important?
|
|
2015.09.08 |
6028 |
| 97 |
[2015 Jun;39(3)] Effect of Low Frequency Neuromuscular Electrical Stimulation on Glucose Profile of Persons with Type 2 Diabetes: A Pilot Study
|
|
2015.07.07 |
6043 |
| 96 |
[2015 Jun;39(3)] Optimal Waist Circumference Cutoff Value Based on Insulin Resistance and Visceral Obesity in Koreans with Type 2 Diabetes
|
|
2015.07.07 |
6212 |
| 95 |
[2015 Jun;39(3)] Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
|
|
2015.07.07 |
5979 |
| 94 |
[2015 Jun;39(3)] The Relationship between Anemia and the Initiation of Dialysis in Patients with Type 2 Diabetic Nephropathy
|
|
2015.07.07 |
5945 |
